FrancophonIA/ELRC3.0 huggingface dataset:
English: For practical information about using Exzolt, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Exzolt naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
English: How is Exzolt used?
Slovenian: Kako se zdravilo Exzolt uporablja?
English: How does Exzolt work?
Slovenian: Kako zdravilo Exzolt deluje?
English: This usually disappears within one to four weeks.
Slovenian: Ta navadno izgine v enem do štirih tednih.
English: This summary was last updated on 24 October 2007.
Slovenian: Povzetek je bil nazadnje posodobljen 24. oktobra 2007.
English: The marketing authorisation was renewed on 18 April 2005.
Slovenian: Dovoljenje za promet z zdravilom je bilo podaljšano dne 18. aprila 2005.
English: Immunisation against FeLV sub-group A provides full protection against all three sub-groups of the virus: A, B and C.
Slovenian: Cepljenje proti virusu FeLV podskupine A nudi celovito zaščito proti vsem trem podskupinam virusa: A, B in C.
English: Immunity starts at the latest two weeks after the second injection and lasts for a year.
Slovenian: Imunost se razvije najkasneje dva tedna po drugi injekciji in traja eno leto.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Purevax FeLV to MERIAL on 13 April 2000.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Purevax FeLV, veljavno po vsej Evropski uniji, odobrila družbi MERIAL dne 13. aprila 2000.
English: The cats should be revaccinated every year.
Slovenian: Mačke je treba po enem letu znova cepiti.
English: Temporary lethargy (listlessness) and hyperthermia (increased body temperature) may occur for one day, exceptionally for two days.
Slovenian: Lahko se pojavita začasna letargičnost (ravnodušnost) in hipertermija (povišana telesna temperatura), ki trajata en dan ter le izjemoma dva dni.
English: The first injection should be given in cats aged at least eight weeks, with a second injection three to five weeks later.
Slovenian: Prvo injekcijo je treba dati mačkam, ki so stare vsaj osem tednov, druga injekcija pa ji mora slediti tri do pet tednov kasneje.
English: Information on the prescription status of this product may be found on the label/outer package.
Slovenian: Podatki o statusu predpisovanja tega zdravila so na nalepki/zunanji ovojnini.
English: Vaccines work by priming the immune system (the body's natural defences) how to defend itself against diseases.
Slovenian: Cepiva delujejo tako, da imunski sistem (naravne obrambne mehanizme telesa) pripravijo na obrambo proti bolezni.
English: In case of accidental self-injection seek medical advice immediately and show the Package Leaflet or the label to the doctor.
Slovenian: V primeru nenamernega samo-injiciranja se takoj posvetujte z zdravnikom in mu pokažite Navodilo za uporabo ali nalepko na škatli zdravila.
English: The antibodies will help to protect against the disease caused by the virus.
Slovenian: Protitelesa bodo pomagala ščititi mačke proti bolezni, ki jo povzroča ta virus.
English: The vaccine is used to prevent the symptoms of the disease and to prevent FeLV from remaining in the blood.
Slovenian: Cepivo se uporablja za preprečevanje simptomov bolezni in preprečevanje zadrževanja virusa FeLV v krvi.
English: The canarypox viruses do not spread or multiply in the cat but they do produce proteins from the FeLV genes.
Slovenian: Poxvirusi kanarčkov se v mački ne širijo in ne množijo, tvorijo pa proteine iz genov virusa FeLV.
English: When a cat is given the vaccine, the immune system recognises the FeLV proteins as ‘foreign' and makes antibodies against them.
Slovenian: Kadar mačka prejme cepivo, imunski sistem prepozna beljakovine virusa FeLV kot „tuje“ in začne proti njim tvoriti protitelesa.
English: In the future, the immune system will be able to produce antibodies more quickly when it is exposed to the FeLV.
Slovenian: V prihodnosti lahko imunski sistem ob izpostavitvi virusu FeLV hitreje ustvarja protitelesa.
English: The effectiveness of Purevax FeLV has been studied in several trials in laboratory conditions where cats were vaccinated and infected with FeLV.
Slovenian: Učinkovitost zdravila Purevax FeLV so raziskali v več preizkušanjih v laboratorijskih pogojih, pri katerih so mačke cepili in okužili z virusom FeLV.
English: The benefit-risk balance may be found in module 6 of this EPAR.
Slovenian: Razmerje med koristmi in tveganji je v modulu 6 tega Evropskega javnega poročila o oceni zdravila (EPAR).
English: A 1 ml dose of Purevax FeLV is injected under the skin.
Slovenian: Odmerek 1 ml zdravila Purevax FeLV se vbrizga pod kožo.
English: A temporary small nodule (hard lump) may appear at the site of injection.
Slovenian: Na mestu vbrizganja se lahko začasno pojavi manjši vozlič (trda bula).
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) PUREVAX FELV EPAR summary for the public
Slovenian: EMEA/V/C/056 EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) PUREVAX FELV Povzetek EPAR za javnost
English: Other information about Purevax FeLV:
Slovenian: Druge informacije o zdravilu Purevax FeLV:
English: In all trials, the main measure of effectiveness was the presence of antibodies against the virus and infectious FeLV in the vaccinated kittens' blood.
Slovenian: V vseh preizkušanjih je bilo glavno merilo učinkovitosti prisotnost protiteles proti virusu in kužnemu virusu FeLV v krvi cepljenih muck.
English: The first evidence of FeLV infection occurred after six weeks in only a few of the kittens vaccinated with Purevax FeLV.
Slovenian: Prvi dokazi o okužbi z virusom FeLV so se pojavili po šestih tednih pri samo majhnem številu muck, ki so jih cepili z zdravilom Purevax FeLV.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Purevax FeLV exceed the risks for active immunisation of cats eight weeks of age or older against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease, and recommended that Purevax FeLV be given a marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila Purevax FeLV pri aktivni imunizaciji mačk, starih osem tednov ali več, proti mačji levkemiji za preprečevanje perzistentne viremije in kliničnih znakov z njo povezane bolezni, večje od z njim povezanih tveganj, ter je priporočil odobritev dovoljenja za promet z zdravilom Purevax FeLV.
English: Purevax FeLV should not be used in pregnant cats.
Slovenian: Zdravila Purevax FeLV ne bi smeli uporabljati pri brejih mačkah.
English: Infection was seen from four weeks in non-vaccinated animals.
Slovenian: Okužbo pri živalih, ki jih niso cepili, so opazili od četrtega tedna dalje.
English: What benefit has Purevax FeLV shown during the studies?
Slovenian: Kakšne koristi je zdravilo Purevax FeLV izkazalo med študijami?
English: The vaccinated kittens were housed for up to 28 weeks with a group of kittens who were infected with FeLV.
Slovenian: Cepljene mucke so za največ 28 tednov nastanili s skupino muck, ki so bile okužene z virusom FeLV.
English: In the field, efficacy has been studied in one main study of kittens aged eight weeks or older, in which the effects of Purevax FeLV were compared with those of another vaccine against FeLV.
Slovenian: Na terenu so izvedli eno glavno študijo na muckah, ki so bile stare osem tednov ali več, pri katerih so učinke zdravila Purevax FeLV primerjali z učinki drugega cepiva proti virusu FeLV.
English: For a full list of all side effects reported with Purevax FeLV, see the Package Leaflet.
Slovenian: Za celoten opis neželenih učinkov, o katerih so poročali pri uporabi zdravila Purevax FeLV, glejte Navodilo za uporabo.
English: Purevax FeLV contains genes from the FeLV sub-group A called env and gag which have been inserted into another vector (carrier) virus called canarypox using ‘recombinant DNA technology'.
Slovenian: Zdravilo Purevax FeLV vsebuje gene virusa FeLV podskupine A, imenovane env in gag, ki so jih s pomočjo „tehnologije rekombinantne DNA“ vstavili v drug vektorski (prenašalni) virus, imenovan poxvirus kanarčkov.
English: Purevax FeLV is used to vaccinate cats from the age of eight weeks against feline leukaemia, an illness affecting the immune system caused by a type of virus known as a retrovirus.
Slovenian: Zdravilo Purevax FeLV se uporablja za cepljenje mačk, starih osem tednov ali več, proti mačji levkemiji, bolezni, ki prizadene imunski sistem in jo povzroča tip virusa, znan tudi kot retrovirus.
English: Purevax FeLV vaccine provided protection against FeLV infection.
Slovenian: Cepivo Purevax FeLV je ustvarilo zaščito proti okužbi z virusom FeLV.
English: What is the risk associated with Purevax FeLV?
Slovenian: Kakšna tveganja so povezana z zdravilom Purevax FeLV?
English: Purevax FeLV is a vaccine containing feline leukaemia virus (FeLV) recombinant canarypox virus (vCP97).
Slovenian: Zdravilo Purevax FeLV je cepivo z rekombinantnim poxvirusom kanarčkov (vCP97), ki vsebuje antigen virusa mačje levkemije (FeLV).
English: Purevax FeLV is presented as a suspension for injection.
Slovenian: Zdravilo Purevax FeLV je suspenzija za injiciranje.
English: Purevax FeLV is a vaccine.
Slovenian: Zdravilo Purevax FeLV je cepivo.
English: Why has Purevax FeLV been approved?
Slovenian: Zakaj je bilo zdravilo Purevax FeLV odobreno?
English: What is Purevax FeLV?
Slovenian: Kaj je zdravilo Purevax FeLV?
English: How has Purevax FeLV been studied?
Slovenian: Kako je bilo zdravilo Purevax FeLV raziskano?
English: What is Purevax FeLV used for?
Slovenian: Za kaj se zdravilo Purevax FeLV uporablja?
English: How does Purevax FeLV work?
Slovenian: Kako zdravilo Purevax FeLV deluje?
English: to you and your child.
Slovenian: za vas in vašega otroka.
English: Date of first authorisation: 28 April 2017
Slovenian: Datum prve odobritve: 28. april 2017
English: - Risk management plan (RMP)
Slovenian: - Načrt za obvladovanje tveganj (RMP)
English: with food and drink
Slovenian: skupaj s hrano in pijačo
English: should not be given to adolescents with existing kidney problems.
Slovenian: se ne sme dajati mladostnikom z obstoječimi ledvičnimi težavami.
English: may be considered during pregnancy, if necessary.
Slovenian: med nosečnostjo, če je potrebno.
English: (see sections 4.2, 4.4 and 5.2).
Slovenian: (glejte poglavja 4.2, 4.4 in 5.2).
English: less frequently.
Slovenian: uporabljate manj pogosto.
English: contains lactose later in this section).
Slovenian: vsebuje laktozo v nadaljevanju tega poglavja).
English: has not been studied in patients over 65 years of age.
Slovenian: niso proučevali pri bolnikih, starejših od 65 let.
English: is not for use in children under 12 years of age.
Slovenian: ne smejo uporabljati otroci, mlajši od 12 let.
English: This is because the active substances in this medicine pass into human breast milk.
Slovenian: To je zato, ker zdravilni učinkovini tega zdravila prehajata v materino mleko.
English: you may still develop infections or other illnesses associated with HIV infection.
Slovenian: lahko še vedno pride do okužbe ali drugih bolezni, povezanih z okužbo s HIV.
English: should only be used in individuals with creatinine clearance (CrCl) <80 mL/min if the potential benefits are considered to outweigh the potential risks.
Slovenian: se sme uporabljati samo pri posameznikih z očistkom kreatinina (CrCl) < 80 ml/min, če se oceni, da morebitne koristi odtehtajo morebitna tveganja.
English: Periodic safety update reports (PSURs)
Slovenian: - Redno posodobljena poročila o varnosti zdravila (PSUR)
English: contains sodium".
Slovenian: vsebuje natrij".
English: can cause dizziness.
Slovenian: lahko povzroči omotičnost.
English: may affect your kidneys.
Slovenian: lahko vpliva na ledvice.
English: should also be considered in case of progressive decline of renal function when no other cause has been identified.
Slovenian: je treba razmisliti tudi v primeru progresivnega upada ledvične funkcije, če ni bil ugotovljen noben drug razlog.
English: KRKA-POLSKA Sp. z o.o.
Slovenian: Polska KRKA-POLSKA Sp. z o.o.
English: is taken with food.
Slovenian: jemlje s hrano.
English: If concomitant use with nephrotoxic agents is unavoidable, renal function should be monitored weekly.
Slovenian: Če je sočasna uporaba z nefrotoksičnegim zdravilom neizogibna, je treba tedensko nadzirati ledvično funkcijo.
English: should always be used combined with other medicines to treat HIV infection.
Slovenian: je treba vedno uporabljati v kombinaciji z drugimi zdravili za zdravljenje okužbe z virusom HIV.
English: at a prolonged dosing interval.
Slovenian: s podaljšanim intervalom med odmerki.
English: is not recommended if you have severe kidney disease or are on dialysis.
Slovenian: ni priporočljiva, če imate hudo ledvično obolenje ali ste na dializi.
English: during your pregnancy, your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child.
Slovenian: jemali med nosečnostjo, vas lahko zdravnik naroči na redne preiskave krvi in druge diagnostične preiskave, da bo spremljal razvoj vašega otroka.
English: is:
Slovenian: je:
English: should not be used during breast-feeding.
Slovenian: med dojenjem ne sme uporabljati.
English: - It is also used to treat HIV in adolescents aged 12 to less than 18 years who weigh at least 35 kg, and who have already been treated with other HIV medicines that are no longer effective or have caused side effects.
Slovenian: - Uporablja se tudi za zdravljenje okužbe z virusom HIV pri mladostnikih, starih 12 let do manj kot 18 let, s telesno maso vsaj 35 kg, ki so se predhodno že zdravili z drugimi zdravili za zdravljenje okužbe s HIV, ki pa več ne učinkujejo ali so povzročila neželene učinke.
English: with other antiretroviral medicines.
Slovenian: skupaj z drugimi protiretrovirusnimi zdravili.
English: rhabdomyolysis 1, muscular weakness
Slovenian: rabdomioliza 1, mišična oslabelost
English: for the treatment of HIV-1 infection, it is recommended that creatinine clearance is calculated in all individuals.
Slovenian: za zdravljenje okužbe s HIV-1 se priporoča izračun očistka kreatinina pri vseh posameznikih.
English: with other antiviral medicines that contain didanosine can raise the levels of didanosine in your blood and may reduce CD4 cell counts.
Slovenian: z drugimi protivirusnimi zdravili, ki vsebujejo didanozin, lahko zviša nivoje didanozina v krvi in zmanjša število celic CD4.
English: 2 to 15 years) were exposed to tenofovir disoproxil for a median of 331 weeks.
Slovenian: (razpon od 2 do 15 let) izpostavljenih dizoproksiltenofoviratu za mediano obdobje 331 tednov.
English: A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with emtricitabine and tenofovir disoproxil.
Slovenian: Veliko število podatkov pri nosečnicah (več kot 1.000 izpostavljenih nosečnosti) ne kaže na malformacijes ali feto/neonatalno toksičnost povezane z emtricitabinom in dizoproksiltenofoviratom.
English: Moreover, the reversibility of renal toxicity cannot be fully ascertained.
Slovenian: Tudi reverzibilnosti toksičnosti za ledvice ni mogoče z gotovostjo določiti.
English: Adults and adolescents aged 12 years and older, weighing at least 35 kg: One tablet, once daily.
Slovenian: Odrasli in mladostniki, stari 12 let in več, s telesno maso vsaj 35 kg: Ena tableta, enkrat dnevno.
English: is missed by more than 12 hours and it is almost time for the next dose, the missed dose should not be taken and the usual dosing schedule should be resumed.
Slovenian: za več kot 12 ur in je že skoraj čas za naslednji odmerek, se izpuščenega odmerka ne sme vzeti in se nadaljuje z jemanjem po običajnem režimu odmerjanja.
English: Manufacturers
Slovenian: Proizvajalec
English: 200 mg/245 mg film-coated tablets
Slovenian: 200 mg/245 mg filmsko obložene tablete
English: is not recommended in patients with severe renal impairment (creatinine clearance < 30 mL/min) and in patients who require haemodialysis since appropriate dose reductions cannot be achieved with the combination tablet (see sections 4.2 and 5.2).
Slovenian: se ne priporoča pri bolnikih s hudo ledvično okvaro (očistek kreatinina < 30 ml/min) in bolnikih, ki potrebujejo hemodializo, ker ustreznega zmanjšanja odmerka ni mogoče doseči s kombinirano tableto (glejte poglavji 4.2 in 5.2).
English: Stopping tablets may reduce the effectiveness of the anti-HIV therapy recommended by your doctor.
Slovenian: - Prenehanje zdravljenja lahko zmanjša učinkovitost zdravljenja okužbe s HIV, ki vam ga je predpisal zdravnik.
English: with other medicines that can damage your kidneys: it is especially important to tell your doctor if you are taking any of these medicines, including aminoglycosides (for bacterial infection) amphotericin B (for fungal infection) foscarnet (for viral infection) ganciclovir (for viral infection) pentamidine (for infections)
Slovenian: z drugimi zdravili, ki lahko poškodujejo vaše ledvice: posebno pomembno je, da svojega zdravnika obvestite, če jemljete katero od sledečih zdravil: - aminoglikozidi (za bakterijsko okužbo) - amfotericin B (za glivno okužbo) - foskarnet (za virusno okužbo)
English: therapy in patients infected with HBV may be associated with severe acute exacerbations of hepatitis.
Slovenian: pri bolnikih z okužbo s HBV je lahko povezana s hudimi akutnimi poslabšanji hepatitisa.
English: Table 2: Interactions between the individual components of emtricitabine/tenofovir disoproxil and other medicinal products
Slovenian: Preglednica 2: Interakcije med posamičnimi učinkovinami emtricitabina/dizoproksiltenofovirata in drugimi zdravili
English: with medicinal products that reduce renal function or compete for active tubular secretion (e.g. cidofovir) may increase serum concentrations of emtricitabine, tenofovir and/or the co-administered medicinal products.
Slovenian: in zdravil, ki zmanjšujejo delovanje ledvic ali tekmujejo za aktivno tubularno sekrecijo (npr. cidofovir), lahko poveča serumske koncentracije emtricitabina, tenofovirja in/ali sočasno uporabljenih zdravil.
English: Transmission of HIV:
Slovenian: Prenos virusa HIV
English: should be taken as soon as possible and the normal dosing schedule should be resumed.
Slovenian: takoj, ko je mogoče, nato pa nadaljevati z običajnim režimom odmerjanja.
English: A multidisciplinary approach is recommended to weigh the benefit/risk balance of the use of emtricitabine/tenofovir, decide the appropriate monitoring during treatment (including decision for treatment withdrawal) and consider the need for supplementation on a case by case basis.
Slovenian: Zato se priporoča multidisciplinarni pristop, s katerim se za vsakega posameznega bolnika ustrezno presodi o razmerju med koristmi in tveganji zdravljenja, sprejme odločitev glede ustreznega spremljanja med zdravljenjem (vključno z odločitvijo o prenehanju zdravljenja) ter razmisli o potrebi po dodatnem zdravljenju.
English: can be administered in place of emtricitabine and tenofovir disoproxil used separately at the same doses.
Slovenian: se lahko jemlje namesto emtricitabina in dizoproksiltenofovirata, ki se uporabljata ločeno v enakih odmerkih.
English: Adolescents aged 12 to less than 18 years who weigh at least 35 kg: one tablet each day, whenever possible with food.
Slovenian: - Mladostniki, stari od 12 do manj kot 18 let, s telesno maso vsaj 35 kg: ena tableta vsak dan s hrano, če je mogoče.
English: is used to treat Human Immunodeficiency Virus 1 (HIV-1) infection in adults.
Slovenian: se uporablja za zdravljenje okužbe z virusom HIV-1 (virus človeške imunske pomanjkljivosti 1) pri odraslih.
English: Administration every 48 hours is recommended based on modelling of single-dose pharmacokinetic data for emtricitabine and tenofovir disoproxil in non-HIV infected subjects with varying degrees of renal impairment (see section 4.4).
Slovenian: Priporočljiv je odmerek vsakih 48 ur, kar temelji na podatkih o farmakokinetiki enkratnih odmerkov za emtricitabin in dizoproksiltenofovirat pri osebah, ki niso okužene s HIV, z različnimi stopnjami ledvične okvare (glejte poglavje 4.4).
English: 28 film-coated tablets: EU/1/17/1182/001 84 film-coated tablets: EU/1/17/1182/003
Slovenian: 28 filmsko obloženih tablet: EU/1/17/1182/001 84 filmsko obloženih tablet: EU/1/17/1182/003
English: is available also in bottles of 30 tablets, with a childresistant tamper evident plastic closure with integrated a silica gel desiccant, which helps to protect your tablets.
Slovenian: je na voljo tudi v plastenkah po 30 tablet s polipropilensko za otroke varno zaporko, ki je ni mogoče odpreti brez vidnih poškodb, z integriranim sušilnim sredstvom iz silikagela, ki pomaga zaščititi vaše tablete.
English: - That a multidisciplinary approach is recommended for the management of paediatric patients - That there is an increased risk of renal disease in HIV infected patients associated with tenofovir disoproxil-containing products such as Emtricitabine/Tenofovir disoproxil Krka d.d.
Slovenian: - da se za vodenje pediatričnih bolnikov priporoča multidisciplinarni pristop; - da obstaja povečano tveganje za ledvično bolezen pri bolnikih s HIV, povezano z zdravili, ki vsebujejo dizoproksiltenofovirat, kot je zdravilo Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Emtricitabine triphosphate and tenofovir diphosphate competitively inhibit HIV-1 reverse transcriptase, resulting in DNA chain termination.
Slovenian: Emtricitabin trifosfat in tenofovir difosfat kompetitivno inhibirata HIV1 reverzno transkriptazo, kar rezultira v prekinitvi verige DNA.
English: is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults (see section 5.1).
Slovenian: je indicirano v kombinirani protiretrovirusni terapiji za zdravljenje odraslih, okuženih s HIV-1 (glejte poglavje 5.1).
English: Shelf life after first opening of the bottle: 2 months.
Slovenian: Rok uporabnosti po prvem odprtju plastenke: 2 meseca
English: is used in patients with creatinine clearance < 60 mL/min, and renal function should be closely monitored.
Slovenian: pri bolnikih z očistkom kreatinina < 60 ml/min in skrbno spremljati delovanje ledvic.
English: is available in carton boxes of 28 and 84 film-coated tablets in blisters.
Slovenian: je na voljo v škatlah po 28 in 84 filmsko obloženih tablet v pretisnih omotih.
English: vancomycin (for bacterial infection) interleukin-2 (to treat cancer) cidofovir (for viral infection) non-steroidal anti-inflammatory drugs (NSAIDs, to relieve bone or muscle pains)
Slovenian: - ganciklovir (za virusno okužbo) - pentamidin (za okužbe) - vankomicin (za bakterijsko okužbo) - interlevkin-2 (za zdravljenje raka) - cidofovir (za virusno okužbo) - nesteroidna protivnetna zdravila (NSAID, za lajšanje bolečin v kosteh ali mišicah)
English: Some patients taking combination antiretroviral medicines such as emtricitabine/tenofovir disoproxil may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
Slovenian: Pri nekaterih bolnikih, ki jemljejo kombinirana protiretrovirusna zdravila, kot je emtricitabin/dizoproksiltenofovirat, se lahko pojavi bolezen kosti, imenovana osteonekroza (odmiranje kostnega tkiva zaradi nezadostne prekrvitve kosti).
English: with other medicines containing didanosine (for treatment of HIV infection): Taking Emtricitabine/Tenofovir disoproxil Krka d.d.
Slovenian: z drugimi zdravili, ki vsebujejo didanozin (za zdravljenje okužbe z virusom HIV): jemanje zdravila Emtricitabin/dizoproksiltenofovirat Krka d.d.
English: In some patients with advanced liver disease or cirrhosis, stopping treatment is not recommended as this may lead to worsening of your hepatitis, which may be lifethreatening.
Slovenian: Pri nekaterih bolnikih z napredovalim obolenjem jeter ali cirozo prenehanje zdravljenja ni priporočljivo, saj lahko to povzroči poslabšanje hepatitisa, kar lahko ogrozi življenje.